Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer. In the results of a study published Nov. 6 in Nature ...
REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...
REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene ...
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s ...
Archaeologists in Norway have confirmed that an ancient set of human remains known as the Well Man were intended to make the locals unwell. By Franz Lidz Long after his death, Hans Jonathan is ...
For 25 years, Iceland’s deCODE Genetics has been one of the most powerful and prolific producers and analyzers of human genomic sequence data. Founded by neurologist Kári Stefánsson, deCODE has ...
Amgen has agreed to acquire deCode Genetics for $415 million. Based in Reykjavik, Iceland, deCode deciphers the links between genetics and human diseases largely by relying on Iceland’s exceptionally ...
NEW YORK (CBS.MW) -- Shares of DeCode Genetics rose nearly 25 percent Tuesday after the company said it expanded a genetic research partnership with Switzerland's Roche AG. Financial terms weren't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback